Clue fans, here’s scientific proof that it was Colonel Mustard with a candlestick

When we last heard from Eve Armstrong one year ago today, she was a postdoc at the BioCircuits Institute at the University of California, San Diego, musing mathematically about what would have happened if she had asked one Barry Cottonfield to her high school prom in 1997. Today, she is a postdoc at the Computational … Continue reading Clue fans, here’s scientific proof that it was Colonel Mustard with a candlestick

Weekend reads: “Weaponized transparency;” fighting academic spam with humor; NIH cracks down

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, would you consider a tax-deductible donation of $25, or a recurring donation of an amount of your choosing, to support it? Thanks in advance. The week at Retraction Watch featured a major case of misconduct at The Ohio State University, … Continue reading Weekend reads: “Weaponized transparency;” fighting academic spam with humor; NIH cracks down

Ohio State just released a 75-page report finding misconduct by a cancer researcher. What can we learn?

Today, the Ohio State University (OSU) announced that Ching-Shih Chen, who resigned from a professorship there in September, was guilty of “deviating from the accepted practices of image handling and figure generation and intentionally falsifying data” in 14 images from eight papers. Chen had earned more than $8 million in Federal grants, and his work … Continue reading Ohio State just released a 75-page report finding misconduct by a cancer researcher. What can we learn?

Nature journal retracts controversial CRISPR paper after authors admit results may be wrong

Nature Methods has retracted a 2017 paper suggesting a common gene editing technique may cause widespread collateral damage to the genome. The notice has a long backstory: After the paper was published, it immediately drew an outcry from critics (including representatives from companies who sell the tool, whose stock fell after publication). Some critics argued … Continue reading Nature journal retracts controversial CRISPR paper after authors admit results may be wrong

Authors claim clinical trial data came from one center. It came from three.

A BMJ journal has retracted a 2017 paper that made a false claim about the clinical trial in question.  The Acupuncture in Medicine paper reported the results of a clinical trial about the impact of acupuncture and Chinese herbal medicine on stroke, gathered from one center. However, in November, the editors of the journal discovered that … Continue reading Authors claim clinical trial data came from one center. It came from three.

Figures in cancer paper at root of newly failed compound called into question

How much role did a potentially problematic paper play in the demise of a once-promising compound? Researchers are questioning the validity of a high-profile article, published by Nature in 2006. Although the letter is 12 years old, the concerns have current implications: It was among the early evidence used to develop a cancer compound that … Continue reading Figures in cancer paper at root of newly failed compound called into question

Caught Our Notice: Voinnet co-author issues another correction

Title: AtsPLA2-α nuclear relocalization by the Arabidopsis transcription factor AtMYB30 leads to repression of the plant defense response What Caught Our Attention:  A previous collaborator with high-profile plant biologist Olivier Voinnet (who now has eight retractions) has issued an interesting correction to a 2010 PNAS paper. Susana Rivas is last author on the paper, the … Continue reading Caught Our Notice: Voinnet co-author issues another correction

Why one journal will no longer accept author-suggested reviewers

In a recent editorial, the Journal of Neurochemistry declared it would no longer accept author-suggested reviewers. While other journals have done the same in order to prevent fake reviews, the Journal of Neurochemistry is basing its decision on a different logic. We spoke with editor Jörg Schulz about why he believes relying on reviewers picked by editors helps … Continue reading Why one journal will no longer accept author-suggested reviewers

“The ‘1’ key was not pressed hard enough:” Did a typo kill a cancer paper?

Errors in a 2017 paper about a new cancer test may have occurred because of a simple typo while performing calculations of the tool’s effectiveness. According to the last author, the “1” key was likely not pressed hard enough. The error, however small, affected key values “so greatly that the conclusions of the paper can … Continue reading “The ‘1’ key was not pressed hard enough:” Did a typo kill a cancer paper?

Cancer biologist retracts five papers

A cancer researcher based at The Ohio State University has retracted five papers from one journal, citing concerns about figures. The notices for all five papers state the Journal of Biological Chemistry raised questions about some figures, and the authors were not able to supply raw data in all instances. Four of the notices say … Continue reading Cancer biologist retracts five papers